Case Report of a Pituitary Macroadenoma Treated With Artemether
Open Access
- 1 December 2006
- journal article
- case report
- Published by SAGE Publications in Integrative Cancer Therapies
- Vol. 5 (4) , 391-394
Abstract
Introduction: This report describes the case of a male patient with pituitary macroadenoma treated with the artemisinin analog artemether. Patient and Methods: A 75 year-old male patient presented with vision, hearing, and locomotion-related problems. Artemether was administered orally to the patient over a period of 12 months. Results: Although the tumor remained consistent in size, CT scan shows a reduction in its density, and clinically, the related symptoms and signs resolved significantly as therapy progressed. Discussion: Overall, the artemether treatment was beneficial in improving the patient's quality of life. Artemether and other artemisinin analogs offer promise for cancer therapy.Keywords
This publication has 20 references indexed in Scilit:
- Observation Alone after Transsphenoidal Surgery for Nonfunctioning Pituitary MacroadenomaThe Journal of Clinical Endocrinology & Metabolism, 2006
- Intermediate-term toxicity of repeated orally administered doses of the anti-malarial β-artemether in dogsExperimental and Toxicologic Pathology, 2006
- Fully Endoscopic Endonasal vs. Transseptal Transsphenoidal Pituitary Surgerymin - Minimally Invasive Neurosurgery, 2005
- Multifunctional Cells in Human Pituitary Adenomas: Implications for Paradoxical Secretion and TumorigenesisThe Journal of Clinical Endocrinology & Metabolism, 2004
- The prevalence of pituitary adenomasCancer, 2004
- Case report of a laryngeal squamous cell carcinoma treated with artesunate2002
- Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trialThe Lancet, 2000
- External irradiation of macroinvasive pituitary adenomas with telecobalt: A retrospective study with long-term follow-up in patients irradiated with doses mostly of between 40–45 GyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
- Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrinCancer Letters, 1995
- Hemin-catalyzed decomposition of artemisinin (qinghaosu)Biochemical Pharmacology, 1992